牙周炎患者龈沟液白细胞介素—1β检测及意义

目的：检测牙周炎患者龈沟液（gingival crevicular fluid,GCF)中白细胞介素－1β(interleukin-1β,IL-1β)的含量,探讨IL－1β在牙周炎发病中的作用。方法：用滤纸条浸润法采集正常成年人及成年人牙周炎患者治疗前后GCF样本,用酶联免疫吸附法（ELISA）检测GCF中IL－1β含量变化,牙周炎患者龈沟液中IL－1β水平显著高于正常对照组（P＜0．01）,牙周炎治疗组患者龈沟液中IL－1β水平较牙周炎组显著降低（P＜0．01）,龈沟液中IL－1β水平分别与牙龈指数,探诊出血指数,牙周袋深呈显著正相关,结论：IL－1β参与牙周炎的发生和发展,GCF中IL－1β可作为检查牙周病活动情况的一项较为敏感的指标。     

三种感染性疾病降钙素原水平比较

目的探讨降钙素原(PCT)辅助细菌性脓毒症诊断的可靠性,以及在革兰阴性菌和革兰阳性菌感染鉴别中的意义。方法本项目收集的研究对象为2013年1月-2018年12月,深圳市龙岗中心医院感染科收治的细菌性脓毒症患者131例、登革热患者30例,流行性感冒患者30例。分别检测三组患者体内PCT水平。结果脓毒症组PCT为2.30(0.18,100)ng/ml高于登革热组0.27(0.09,0.54)ng/ml(P<0.001)及流感组0.04(0.01,0.35)ng/ml(P<0.001);而登革热组与流感组相比,PCT浓度则无统计学意义(P=0.128);其次,在脓毒症组中,革兰阴性菌感染者的PCT浓度高于革兰阳性菌感染者(P<0.001)。结论 PCT高浓度对细菌性脓毒症的诊断精确可靠。另外,革兰阴性菌和革兰阳性菌感染者体内降钙素原的浓度明显不同,这可作为两种细菌感染的鉴别依据。     

Detection of a novel “cryptic” plasmid of about 7.8 MDal in a non-penicillinase-producing Neisseria gonorrhoeae isolate from Munich

A novel plasmid of about 7.8 megadaltons (MDal) could be detected in a non-penicillinase-producing Neisseria gonorrhoeae strain isolated in Munich in 1987. As the strain showed no resistance against commonly used chemotherapeutic agents, at present the plasmid must be described as phenotypically cryptic.Corresponding author.     

老年人腹腔镜胆囊切除术麻醉的临床研究

为观察异丙酚全凭静脉麻醉在老年人腹腔镜胆囊切除术 (LC)围麻醉期呼吸循环功能的变化 ,以评价其实用性和安全性 ,将 30例ASAⅠ～Ⅱ级患者 ,择期行LC手术 ,以微量泵持续静注异丙酚维持麻醉 (剂量递减法 10～ 8～ 6mg/kg·h-1) ,控制呼吸频率 16～ 2 5 /min ,人工气腹后保持轻度过度通气状态 ,连续监测呼吸循环功能各参数的变化。结果显示 :本组异丙酚平均总用量为 5 6 0± 12 8mg( 8.0 5± 2 .16mg/kg·h-1) ,麻醉诱导后SBP、DBP、MAP一过性降低 (P <0 .0 1) ,于插管后迅速恢复 ;CO2 气腹后PETCO2 开始上升并于 15min后达最高值但在正常范围 ,86 .6 7%的病例于拔管后 5～ 10min麻醉苏醒并能简单答话。认为异丙酚全凭静脉维持麻醉用于老年人LC并于气腹期轻度过度通气能维持呼吸循环功能的相对稳定 ,且苏醒快 ,术后恢复良好 ,具有实用性和安全性     

Dose and Load Studies for Subcutaneous and Oral Delivery of Poly(lactide-co-glycolide) Microspheres Containing Ovalbumin

Poly(lactide-co-glycolide) microspheres containing different loads of OVA (0.05, 0.1, 0.5 and 1.0% w/w) were manufactured by a w/o/w emulsion/solvent evaporation method. Low load efficiencies of less than 20% were observed. Normal size distributions with mean volume diameters ranging from 3.7 to 4.7 µm were obtained for different batches. The in vitro release of OVA from different loaded microspheres showed an expected burst release with all batches. The in vivo dose study (1, 10, 25, 50 µg of OVA) was performed by subcutaneous and oral inoculation in mice by single (0 week) or double (0 and 3 weeks) administration of PLGA 50/50 microspheres containing 0.1% OVA. Subcutaneous administration showed an immune response (serum Ig levels by ELISA) statistically (Fishers paired t-test; P < 0.05) above OVA saline negative controls at 3, 6 and 12 weeks after administration. Oral administration of microspheres produced statistically higher systemic immune responses at the higher doses. Single and double inoculation orally and subcutaneously produced similar serum antibody levels. The in vivo load study was performed by subcutaneous and oral administration to mice of 25 µg OVA contained in various loaded (0.05, 0.1, 0.5 and 1.0% w/w) microspheres. Serum immune responses at 3, 6, and 12 weeks after inoculation were statistically above OVA saline controls and were inversely proportional to the OVA load using either route. This observation suggested a relationship between the number of microspheres delivered and the in vivo serum response. Single subcutaneous administration of 0.05 or 0.1% OVA loaded PLGA 50/50 microspheres induced larger immune responses compared with complete Freunds adjuvant.     

Alterations of Müller (glial) cells in dystrophic retinae of RCS rats

Summary We have carried out a light microscopical study of Müller cells in the retinae of rats with inherited retinal dystrophy (Royal College of Surgeons rats). Isolated retinae of both control and Royal College of Surgeons rats were exposed to a Procion Yellow solution which is taken up selectively into Müller cells. The shape of the cells was then studied by confocal microscopy. Enzymatically isolated Müller cells were studied immunocytochemically with antibodies against glial fibrillary acidic protein, cathepsin D, -amyloid precursor protein, bcl-2 protooncogene product, and glutamine synthetase. Müller cells from RCS retinae were shorter than those from control retinae, and showed a coarse hypertrophy of their distal (sclerad) processes. In Müller cells isolated from the retinae of Royal College of Surgeon's rats, the expression of glial fibrilliary acidic protein, cathepsin D, -amyloid precursor protein and bcl-2 protooncogene product was increased, and the expression of glutamine synthetase was reduced. Obviously, loss of neighbouring neurons leads to major alterations of both the shape and metabolism of Müller cells. The expression of enzymes that serve functional glio-neuronal interactions, such as glutamine synthetase, seems to be down-regulated, whereas proteins involved in cell reconstruction (cathepsin D), cell repair (possibly -amyloid precursor protein), and protection against apoptotic cell death (bcl-2 protooncogene product), are up-regulated, together with the pathological marker glial fibrilliary acidic protein.     

Treatment of pains from bone metastases with 90Y (author's transl)

For palliation of pain caused by bone metastases beta radiation isotope therapy was successful. As shown in experimental work on animals bone uptake of 90Y with its shorter half-life is high when it is administered as a citrate complex. 90Y can be eluted with high purity from a 90Sr "cow". The retention in man was found by whole-body counting to be higher than 80%. In preliminary trials on 16 patients the analgetic effect was the same as that of 89Sr. The properties of 90Y therapy are discussed.     

薄荷油β-环糊精包合物的制备研究

目的：研究β-环糊精包合薄荷油的最佳工艺。方法：采用正交试验法，以挥发油包合率为指标。结果：优选出最佳包合工艺为：薄荷油：β-环糊精=1：8，包合温度45℃，包合时间1．5h，薄荷油无需稀释，挥发油包合率为86．O％。结论：该法适合大生产。     

磷脂聚合物在医药学中的应用

目的在简介磷脂的基础上 ,概括了磷脂类似物和磷脂聚合物的合成方法及其在医药领域中的应用。方法在参阅国内外相关文献的基础上 ,进行分析、整理和归纳。结果磷脂聚合物的合成方法已经发展的比较成熟 ,但是在医药方面的应用主要限于磷脂聚合物型脂质体、聚乙二醇(PEG)修饰型脂质体和磷脂修饰型聚合物。结论具有两亲性和生物相容性的磷脂及其聚合物在医药领域具有广泛的发展前景